RT Journal Article
SR Electronic
T1 Continuous non-invasive hemodynamic monitoring in early onset severe preeclampsia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.10.23288375
DO 10.1101/2023.04.10.23288375
A1 Ackerman-Banks, Christina M
A1 Bhinder, Jasjit
A1 Eder, Maxwell
A1 Heerdt, Paul
A1 Sugeng, Lissa
A1 Testani, Jeffrey
A1 Alian, Aymen
A1 Lipkind, Heather
A1 Velazquez, Eric
A1 Reddy, Uma
A1 Chou, Josephine C
YR 2023
UL http://medrxiv.org/content/early/2023/04/11/2023.04.10.23288375.abstract
AB Objectives Continuous hemodynamic monitoring offers the opportunity to individualize management in severe preeclampsia (PEC). We compared cardiac output (CO) and systemic vascular resistance (SVR) measured by bioreactance (NICOM), Clearsite™ Fingercuff [CS), and 3D-echocardiography (3DE).Study Design This prospective observational study included 12 pregnant patients with early PEC. CO and SVR were measured simultaneously by NICOM, CS, and 3DE antepartum and 1-2 days postpartum. Using 3DE as the standard, CS and NICOM interchangeability, precision, accuracy, and correlation were assessed.Results Compared to 3DE-CO, CS-CO was highly correlated (R2=0.70, p=<0.0001) with low percentage error (PE 29%) which met criteria for interchangeablity. CS-SVR had strong correlation (R2=0.81, p=<0.0001) and low PE (29%). While CS tended to slightly overestimate CO (bias +2.05 +/-1.18 L/min, limit of agreement (LOA) -0.20-4.31) and underestimate SVR (bias -279 +/-156 dyes/sec/cm5; LOA -580-18.4) these differences were unlikely to be clinically significant. Thus CS could be interchangeable with 3DE for CO and SVR. NICOM-CO had only moderate correlation with 3DE-CO (R2=0.29, p=0.01) with high PE (52%) above threshold for interchangeability. NICOM-CO had low mean bias (−1.2 +/-1.68 L/min) but wide 95% LOA (−4.41 - 2.14) suggesting adequate accuracy but low precision in relation to 3DE-CO. NICOM-SVR had poor correlation with 3DE-SVR (R2=0.32, p=0.001) with high PE (67%), relatively low mean bias (238 +/-256), and wide 95% LOA (– 655–1131). NICOM did not meet the criteria for interchangeable with 3DE for CO and SVR.Conclusions Clearsite Fingercuff, but not NICOM, has potential to be clinically useful for CO and SVR monitoring in severe preeclampsia.Competing Interest StatementDr Josephine Chou is a consultant for abiomed. The remaining authors declare no conflicts of interest.Funding StatementThe research reported in this publication was supported by the Bahn endowment fund from Yale University School of Medicine and the Garite Mini-Sabbatical Grant from the Society for Maternal Fetal Medicine.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Yale School of Medicine Human Investigation Committee ethical approval for this study. All patients signed an informed consent prior to enrollment.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.1PECsevere preeclampsiaCOcardiac outputSVRsystemic vascular resistanceCSClearsite FingercuffNICOMnon-invasive cardiac monitoring with bioreactance3DE33D-echocardiographyPEpercentage errorLOAlimit of agreementHDPhypertensive disorders of pregnancySBPsystolic blood pressureDBPdiastolic blood pressureMAPmean arterial pressuresSVstroke volumeCVPcentral venous pressureLVleft ventricularEFejection fractionBPblood pressureGLSglobal longitudinal strain